| Amira Grace Ebong, DPT | |
|
9521 Gravelly Lake Dr Sw, Lakewood, WA 98499-1513 | |
| (283) 983-9395 | |
| Not Available |
| Full Name | Amira Grace Ebong |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 2 Years |
| Location | 9521 Gravelly Lake Dr Sw, Lakewood, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194463265 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Elite Physical Therapy Llc | 1951295187 | 59 |
News Archive
Corin, a global orthopedic manufacturer and leader in functional implant positioning, today announced the launch of the Trinity Dual Mobility System featuring new implant technology designed to improve range of motion and reduce the risk for instability and dislocation after primary or revision hip replacement.
Emergent BioSolutions Inc. announced today that it has closed on its acquisition of Bracco Diagnostics Inc.'s Healthcare Protective Products Division. This acquisition, which includes the RSDL (decontamination lotion) product that is cleared for marketing by the U.S. Food and Drug Administration for removal or neutralization of chemical warfare agents from the skin, diversifies and broadens Emergent's biodefense franchise into the chemical countermeasure market.
Researchers at Columbia University Medical Center (CUMC) have identified the immune cells responsible for destroying hair follicles in people with alopecia areata, a common autoimmune disease that causes hair loss, and have tested an FDA-approved drug that eliminated these immune cells and restored hair growth in a small number of patients.
Vision-Sciences, Inc. announced today that it has signed a three year agreement under which Vision-Sciences will become the exclusive supplier to Stryker Corporation, through its Endoscopy division, of Stryker-branded flexible video and fiber cystoscopes.
Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections.
› Verified 6 days ago
| Provider Name | Elite Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1225123565 PECOS PAC ID: 1951295187 Enrollment ID: O20040210000311 |
News Archive
Corin, a global orthopedic manufacturer and leader in functional implant positioning, today announced the launch of the Trinity Dual Mobility System featuring new implant technology designed to improve range of motion and reduce the risk for instability and dislocation after primary or revision hip replacement.
Emergent BioSolutions Inc. announced today that it has closed on its acquisition of Bracco Diagnostics Inc.'s Healthcare Protective Products Division. This acquisition, which includes the RSDL (decontamination lotion) product that is cleared for marketing by the U.S. Food and Drug Administration for removal or neutralization of chemical warfare agents from the skin, diversifies and broadens Emergent's biodefense franchise into the chemical countermeasure market.
Researchers at Columbia University Medical Center (CUMC) have identified the immune cells responsible for destroying hair follicles in people with alopecia areata, a common autoimmune disease that causes hair loss, and have tested an FDA-approved drug that eliminated these immune cells and restored hair growth in a small number of patients.
Vision-Sciences, Inc. announced today that it has signed a three year agreement under which Vision-Sciences will become the exclusive supplier to Stryker Corporation, through its Endoscopy division, of Stryker-branded flexible video and fiber cystoscopes.
Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amira Grace Ebong, DPT 6050 Tacoma Mall Blvd Ste 300, Tacoma, WA 98409-6828 Ph: () - | Amira Grace Ebong, DPT 9521 Gravelly Lake Dr Sw, Lakewood, WA 98499-1513 Ph: (283) 983-9395 |
News Archive
Corin, a global orthopedic manufacturer and leader in functional implant positioning, today announced the launch of the Trinity Dual Mobility System featuring new implant technology designed to improve range of motion and reduce the risk for instability and dislocation after primary or revision hip replacement.
Emergent BioSolutions Inc. announced today that it has closed on its acquisition of Bracco Diagnostics Inc.'s Healthcare Protective Products Division. This acquisition, which includes the RSDL (decontamination lotion) product that is cleared for marketing by the U.S. Food and Drug Administration for removal or neutralization of chemical warfare agents from the skin, diversifies and broadens Emergent's biodefense franchise into the chemical countermeasure market.
Researchers at Columbia University Medical Center (CUMC) have identified the immune cells responsible for destroying hair follicles in people with alopecia areata, a common autoimmune disease that causes hair loss, and have tested an FDA-approved drug that eliminated these immune cells and restored hair growth in a small number of patients.
Vision-Sciences, Inc. announced today that it has signed a three year agreement under which Vision-Sciences will become the exclusive supplier to Stryker Corporation, through its Endoscopy division, of Stryker-branded flexible video and fiber cystoscopes.
Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections.
› Verified 6 days ago
Joseph F Staeheli, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8107 Steilacoom Blvd Sw, Lakewood, WA 98498 Phone: 253-584-6555 Fax: 253-584-6926 | |
Samantha L. Gubka, DPT, OCS, CCCE Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 7308 Bridgeport Way W, Suite 103, Lakewood, WA 98499 Phone: 253-582-8142 Fax: 253-582-8160 | |
Jessica Estes, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9315 Gravelly Lake Dr Sw, Suite 306, Lakewood, WA 98499 Phone: 253-581-5200 Fax: 253-581-5203 | |
Brady Houbrick, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10903 Gravelly Lake Dr Sw, Lakewood, WA 98499 Phone: 253-583-5230 | |
Regina Y Lim-yu, Physical Therapist Medicare: Medicare Enrolled Practice Location: 8524 Steilacoom Blvd Sw, Lakewood, WA 98498 Phone: 253-722-5511 | |
Kathleen Erin Hutchinson, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 9514 Gravelly Lake Dr Sw, Lakewood, WA 98499 Phone: 253-983-9395 | |
Jane Dumas, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9521 Gravelly Lake Dr Sw, Lakewood, WA 98499 Phone: 253-983-9395 |